Nuclear Medicine
123I MIBG BACON (R&D)
Name:
123I MIBG Bacon (R&D)
Active Principle:
123I- Meta Iodo Benzylguanidine or 123I- Iobenguane
Therapeutic Action:
It is indicated for: Oncology:
a) Scintigraphic localization of tumors originating in tissues that derive embryologically from the neural crest. These are pheochromocytomas, paragangliomas, chemodectomas, and angioneuromas.
b) Detection, staging and monitoring of response to treatment of neuroblastomas.
c) Evaluation of iobenguane uptake in pheochromocytomas, euroblastomas, carcinoid tumors and medullary thyroid carcinoma. The sensitivity for diagnostic visualization differs according to the pathology.
d) Functional studies of hyperplasia of the adrenal medulla
Cardiology: Functional studies of the sympathetic innervation of the myocardium. This drug can be used as a prognostic indicator of the risk of progression of heart failure, the appearance of life-threatening arrhythmic events, or sudden cardiac death in patients with heart failure in functional class II/III of the NYHA (New York Heart Association). ) and left ventricular dysfunction.
Línea
Nuclear Medicine
Sublínea
SPECT Radiopharmaceuticals
123I MIBG BACON (R&D)
Línea
Nuclear Medicine
Sublínea
SPECT Radiopharmaceuticals
123I MIBG BACON (R&D)
Nuclear Medicine
123I MIBG BACON (R&D)
Name:
123I MIBG Bacon (R&D)
Active Principle:
123I- Meta Iodo Benzylguanidine or 123I- Iobenguane
Therapeutic Action:
It is indicated for: Oncology:
a) Scintigraphic localization of tumors originating in tissues that derive embryologically from the neural crest. These are pheochromocytomas, paragangliomas, chemodectomas, and angioneuromas.
b) Detection, staging and monitoring of response to treatment of neuroblastomas.
c) Evaluation of iobenguane uptake in pheochromocytomas, euroblastomas, carcinoid tumors and medullary thyroid carcinoma. The sensitivity for diagnostic visualization differs according to the pathology.
d) Functional studies of hyperplasia of the adrenal medulla
Cardiology: Functional studies of the sympathetic innervation of the myocardium. This drug can be used as a prognostic indicator of the risk of progression of heart failure, the appearance of life-threatening arrhythmic events, or sudden cardiac death in patients with heart failure in functional class II/III of the NYHA (New York Heart Association). ) and left ventricular dysfunction.
RELATED PRODUCTS
-
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness... -
AV45 (R+D)
AV45 (R+D)It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive... -
PARTITION FLASK
PARTITION FLASKVial containing a mixture of solvents to carry out a chromatographic separation ... -
TECHNETIUM GENERATOR
TECHNETIUM GENERATORIt is indicated for obtaining a solution of Sodium Pertechnetate (Tc99m) ...